Oncology Spotlight

🔬 Join us in this insightful conversation with Dr. Arturo Loaiza-Bonilla, Chief Medical Officer at MassiveBio, as he shares his journey and expertise in the ever-evolving landscape of oncology and artificial intelligence. 🚀

🌐 MassiveBio is at the forefront of transforming cancer care, leveraging AI to optimize workflows, enhance clinical trial matching, and revolutionize drug discovery. Dr. Loaiza-Bonilla delves into his experiences with ontology-based approaches, NLP, OCR, and the emergence of large AI models like GPT-3.

📈 Discover the potential of multi-modal approaches for prognostication in clinical trials and the groundbreaking use of AI in oncology research. Dr. Loaiza-Bonilla emphasizes the need for collaborative efforts to streamline processes, from patient recruitment to post-enrollment engagement.

🤖 As we explore the impact of AI in healthcare, Dr. Loaiza-Bonilla addresses the challenges in adoption, emphasizing the importance of regulatory clarity, incentives, and avoiding the fear of technology replacing human expertise.

👩‍⚕️ Dive into the heart of oncology challenges, where Dr. Loaiza-Bonilla sheds light on the fundamental need for improved biomarker testing. He advocates for patient-centric approaches, automated processes, and removing hurdles to ensure timely and accurate testing.

🌟 Exciting Advances in Cancer Treatment! Dr. Loaiza-Bonilla discusses recent breakthroughs, including bispecific antibodies, gene editing with CRISPR, and the promising developments in ADCs (antibody-drug conjugates). Learn how AI plays a pivotal role in accelerating drug efficacy assessments and in silico trials.

🎗️ Advice for Patients and Caregivers: Dr. Loaiza-Bonilla encourages individuals to be their own advocates, stressing the importance of asking questions, exploring biomarker-driven options, and planning for various treatment scenarios. Remember, your life is your journey, and collaboration with your healthcare team is key.

👨‍⚕️ Dr. Arturo Loaiza-Bonilla's insights are invaluable, providing a glimpse into the future of cancer care and the pivotal role AI plays in advancing treatments. Don't miss out on this engaging and informative conversation!

🔔 Subscribe for more updates on healthcare innovations, AI in medicine, and inspiring conversations with leading experts. Let's empower patients and caregivers on their cancer journey together!

#AIinOncology #CancerTreatment #HealthcareInnovations #MassiveBio #DrArturoLoaizaBonilla #AIRevolution

Welcome to "Oncology Spotlight"! In this episode, we shine light on blood cancer awareness, featuring an exclusive interview with Dr. Hisam Siddiqi, founder of Bread & Butter Hematology, a distinguished figure in the field of haematology. 

Join us as Dr. Siddiqi provides insights into his inspiring journey in medicine, delving into what sparked his passion for this field and why he chose to specialize in haematology. Discover the story behind the creation of "Bread & Butter Hematology," a unique initiative that has been making waves in the haematology community.

Learn about the vision and future plans for "Bread & Butter Hematology," and gain valuable insights into the future of haematology as Hisam Siddiqi shares his perspectives on the most groundbreaking developments and areas of focus in the upcoming decade.

Discover how patient-centered care and support form the cornerstone of Dr. Siddiqi's approach towards individuals dealing with haematology-related challenges. Gain a deeper understanding of the significant obstacles and challenges that haematology professionals face in current medical practice.

Stay tuned as Dr. Siddiqi graciously shares more about the fascinating world of haematology, offering a glimpse into upcoming projects that are set to make a difference. 🌟

🎙️ For more engaging discussions and expert insights, don't forget to subscribe to "Oncology Spotlight".

Welcome to 'Oncology Spotlight,' where we illuminate the world of haematology and dive deep into its intricacies with an inspiring guest, Geraldine Walpole. As a Registered Advanced Nurse Practitioner in Haematology and the Chairperson of Multiple Myeloma Ireland, Geraldine brings a unique perspective to our discussion.

In this episode, Geraldine shares her background, the motivation behind her nursing career, and what led her to specialize in haematology. We also explore the critical initiatives and support services Multiple Myeloma Ireland provides to patients, shedding light on the significance of patient support groups in the journey of those facing haematologic disorders.

Advancements in haematology are a crucial aspect, and Geraldine offers insights into recent breakthroughs in myeloma treatment. Additionally, we discuss the importance of continuous education for healthcare professionals and the challenges faced in haematology care, along with possible solutions.

Collaboration and multidisciplinary care are key components of patient well-being, and Geraldine elaborates on how she collaborates with haematologists and oncologists to ensure comprehensive care. Looking to the future, we explore promising developments and trends in the field of haematology.

Join us in this illuminating conversation, gaining insights from Geraldine's wealth of experience and dedication to improving lives in the realm of haematology.

🎙️ Welcome to another captivating episode of Oncology Spotlight! 🌟

In this episode, we delve deep into the realm of haematology, where groundbreaking discoveries are transforming patient care. Today, we have the honor of hosting, Dr. Liam Smyth, whose career has been dedicated to the study and treatment of haematological disorders.

🩸 Here's a sneak peek at what we'll be discussing:

Introduction and Background:

🔬 Dr. Smyth gives us a glimpse into his remarkable journey and what led him to a career in medicine.

Advancements in Haematology:

🚀 Find out which recent breakthroughs in haematology have left Dr. Smyth excited and inspired.

Lymphoma and Immunotherapies:

🦠 Learn about the pivotal role of immunotherapies in lymphoma treatment, including exciting ongoing clinical trials.

Patient-Centered Care:

❤️ Explore Dr. Smyth's approach to providing not only medical treatment but also emotional support to patients facing haematological disorders.

Collaborative Approach:

🤝 Understand the importance of collaboration among haematologists, oncologists, and other professionals for comprehensive patient care.

Education and Outreach:

📚 Discover common misconceptions about haematological disorders and gain insights into Dr. Smyth's approach to staying updated with the latest developments.

Personal Reflections:

🌟 Hear a heartwarming patient success story that reaffirmed Dr. Smyth's dedication to haematology.

Closing:

🎤 Dr. Smyth shares his final thoughts on haematology, advancements in treatment, and his personal journey in the field.

Join us on this enlightening journey of knowledge and discovery with Dr. Liam Smyth as your guide. Don't miss this opportunity to gain valuable insights into the world of haematology and the future of patient care.

🔗 Stay tuned and subscribe for more engaging episodes of Oncology Spotlight. Let's begin! 🎧👨‍⚕️🩺

Disclaimer: Please note that Amgen Ireland has kindly supported the creation of this video. However, ONCOassist has full control over the content created.

Greetings and a warm welcome to the Oncology Spotlight!

We’re thrilled to introduce the highly esteemed CEO of Cancer Trials Ireland, Mrs. Eibhlín Mulroe. Mrs. Mulroe is a prominent figure in the healthcare industry, recognized for her vast experience and expertise in clinical research and eHealth initiatives.  

As the CEO of Cancer Trials Ireland, Mrs. Mulroe has played a critical role in advancing clinical research in Ireland. Her contribution to the healthcare sector extends beyond her role as CEO, as she also serves on the eHealth Ireland Committee, where she plays an instrumental role in supporting the implementation of the Irish government's Ehealth Strategy. Additionally, she serves as an Advisory Board member of the Cork Clinical Research Centre.

Without further ado, let's delve into an insightful conversation with the brilliant Mrs. Eibhlín Mulroe, CEO of Cancer Trials Ireland! 🎙️

🏥 Healthcare Journey:

Mrs. Mulroe, could you share with us how your journey in the healthcare industry led you to your current role as the CEO of Cancer Trials Ireland? 

⏰ A Day in the Life:

Ever wondered what a typical day looks like for a powerhouse like Mrs. Mulroe? Stick around as we ask her to give us a sneak peek into her busy schedule and how she manages her role as CEO. 📅

💪 Advancing Cancer Treatment:

Clinical trials play a pivotal role in shaping the future of cancer treatment. Join us as Mrs. Mulroe sheds light on the significance of clinical trials and how Cancer Trials Ireland is contributing to this crucial effort. 🩺

📈 Changing Landscape:

The world of cancer trials has transformed significantly over the last two decades. Let's hear from Mrs. Mulroe on how these changes have impacted Ireland and the global scene. 🌎

🧠 Lessons and Learning:

Taking on the role of CEO brings its own set of challenges and growth opportunities. Discover the most profound lessons Mrs. Mulroe has learned during her time at the helm of Cancer Trials Ireland. 📚

🎯 Strategic Objectives:

What are the strategic objectives that Cancer Trials Ireland aims to achieve from 2022 to 2027? Mrs. Mulroe provides insight into the organization's plans for the future. 📊

🌿 Greening Cancer Trials:

A unique initiative by Cancer Trials Ireland, the Greening Cancer Trials initiative, holds great promise. Tune in as we learn more about this environmentally conscious approach to advancing cancer research. 🌱

🚀 Future Initiatives:

What's on the horizon for Cancer Trials Ireland? Mrs. Mulroe unveils upcoming projects and initiatives, offering a glimpse into how the organization is evolving to meet future challenges. 🔍

🌟 Advice for Future Researchers:

Calling all aspiring professionals in clinical research! Mrs. Mulroe imparts valuable advice for those looking to make a positive impact in this dynamic field. 🌟

🔔 Don't forget to hit that notification bell so you never miss out on our engaging interviews with industry leaders like Mrs. Eibhlín Mulroe! Like, share, and subscribe for more enriching content. Stay inspired and informed! 📢

Disclaimer: Please note that MSD Ireland has kindly supported the creation of this video. However, ONCOassist has full control over the content created.

In today's episode, we have Dr. Michiel Strijbos, a Medical Oncologist and healthcare tech enthusiast, who focuses on the research and treatment of GU malignancies. With several task forces and committees under his belt, Dr. Strijbos is also a principal investigator in various clinical trials.

Aside from his impressive academic background, Dr. Strijbos was the chair of the ESMO Practicing Oncologists Working Group and is a member of the Publishing Group and Educational Committee.

We are thrilled to have Dr. Strijbos here to share his insights and perspectives with us. Join us as we dive into the conversation and learn more about his background, what inspired him to pursue a career in medical oncology, and the most rewarding aspects of his work.

We will also discuss his involvement with ESMO and some of the exciting projects he has worked on, as well as his views on the potential of health tech, including the use of AI in oncology.

Dr. Strijbos will share his thoughts on the biggest challenges facing the field of medical oncology and how he sees them being addressed in the future. He will also discuss some of the recent advances in cancer treatment that he finds particularly exciting and promising.

Finally, for patients and caregivers seeking advice on navigating cancer care, Dr. Strijbos will offer his tips and insights.

So, sit back and enjoy Oncology Spotlight with Dr. Michiel Strijbos.

Disclaimer: Please note that MSD Ireland has kindly supported the creation of this video. However, ONCOassist has full control over the content created.

Dr. Conleth Murphy is a Podcaster and Consultant Medical Oncologist based in the Bons Secours Hospital in Cork, Ireland. He talks about gynecologic, urologic malignancies, how patient care is developing, and his story behind starting The Cure Podcast. Know more about Dr. Conleth Murphy: 

Twitter: https://twitter.com/conlethmurphy Listen to
The Cure Podcast: Spotify: is.gd/Hn5Jsp Apple podcast: is.gd/tqxMWz
For inquiries, contact us at info@oncoassist.com
Let's connect: Website: www.oncoassist.com
Twitter: https://twitter.com/oncoassist
LinkedIn: https://www.linkedin.com/showcase/oncoassist
Instagram: https://www.instagram.com/oncoassist/
Facebook: https://www.facebook.com/ONCOassist

Today's Oncology Spotlight is with Dr. Giuseppe Banna, a 46-year old Consultant Medical Oncologist, and father of 2 daughters. His clinical and scientific experience has been mostly focused on thoracic and urology cancer and prognostic and predictive biomarkers for systemic cancer treatments, particularly for immunotherapy. He works at the Department of Oncology of Portsmouth Hospitals University NHS Trust in the UK and his subspecialties are Lung and Urology. He’s Italian and moved to the UK two years ago. Currently, he’s working with his European colleagues on predictive models of efficacy and toxicity of immunotherapy based on immune-inflammatory biomarkers and artificial intelligence. He has a soft spot for the academy and clinical and translational research. In 2017, he was entitled with an Italian qualification to be an Associate Professor. He promoted translational and clinical research trials and joined national and European cancer research networks. He’s the coordinator of the Italian Association of Medical Oncology (AIOM), Italian Germ Cell Cancer Group (IGG) guidelines for testicular germ cell tumors, and also a member of the British Thoracic Oncology Group (BTOG), the International Society of Geriatric Oncology (SIOG), the Italian Urologic Meet-Uro and the EORTC Lung and Urology Cancer Group. In 2011 he co-founded a non-profit organization "Medicare Onlus - You Make It Real" to promote initiatives regarding the primary and secondary prevention of cancer and support cancer patients and their families in the South of Italy. We at ONCOassist had a chance to speak with him about his work and its impact on his life both professionally and personally. His responses during the interview offer meaningful insight into the life of an Oncologist who’s dedicated to providing unparalleled care to his patients. 00:00 Introduction 02:26 Medicare Onlus - You Make It Real 04:25 What would you say excites you the most in your industry? 06:33 Mentions: Alfredo Addeo & Fabio Gomes 09:22 How did you originally find out about ONCOassist and why did you decide to install the app? 16:26 How do you use ONCOassist? 18:02 In your perspective, what health industry problem is ONCOassist well placed to solve?‍ 19:20 Why did you decide to pursue a career in medicine, specifically Oncology? 22:22 What are some of your biggest challenges day-to-day as an Oncologist? 25:22 A positive impact of COVID-19 is the adoption of digital health, can you give us a few examples of your experience around this? 27:29 Mention: ONCOalert & Gil Morgan 29:27 ‍For any patients and caregivers reading this, what are your tips on navigating cancer care? ✅ Know more about: Medicare Onclus: https://www.medicareonlus.com Dr. Giuseppe Banna: https://www.twitter.com/gbanna74 ✅ For inquiries, contact us at info@oncoassist.com ✅ Let's connect: Website: www.oncoassist.com Twitter: https://twitter.com/oncoassist LinkedIn: https://www.linkedin.com/showcase/onc... Instagram:https://www.instagram.com/oncoassist/ Facebook: https://www.facebook.com/ONCOassist/